McClure, David L <br/><br/>
Statin and statin-fibrate use was significantly associated with increased myositis risk in a managed care population.  [electronic resource] 

 -  Journal of clinical epidemiology  Aug 2007 
 - 812-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0895-4356 
<br/><br/><label>Standard No.: </label>10.1016/j.jclinepi.2006.11.006  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Age Factors<br/>Aged<br/>Clofibric Acid--adverse effects<br/>Cohort Studies<br/>Confidence Intervals<br/>Confounding Factors, Epidemiologic<br/>Creatine Kinase--blood<br/>Drug Administration Schedule<br/>Drug Therapy, Combination<br/>Female<br/>Humans<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--adverse effects<br/>Hyperlipidemias--blood<br/>Hypolipidemic Agents--adverse effects<br/>Kidney Diseases--complications<br/>Liver Diseases--complications<br/>Male<br/>Managed Care Programs<br/>Middle Aged<br/>Myositis--blood<br/>Odds Ratio<br/>Proportional Hazards Models<br/>Risk<br/>Risk Assessment<br/>Sex Factors<br/>Time Factors